A complete and durable clinical response to high-dose dexamethasone in a patient with scleromyxedema - 24/08/11
Chicago, Illinois
Abstract |
We report a case of a patient with scleromyxedema limited to the skin with an associated IgG λ monoclonal protein treated successfully with high-dose dexamethasone. We encourage the continued investigation of this complex relationship between the clinical presentation of scleromyxedema and its frequently associated paraproteinemia.
Le texte complet de cet article est disponible en PDF.Plan
This supplement is made possible through the generous support of Stiefel Laboratories for the American Academy of Dermatology. Funding sources: None. Conflicts of interest: None identified. Reprints not available from authors. |
Vol 51 - N° 2S
P. 120-123 - août 2004 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?